Decreased miR-127 promotes the occurrence of breast cancer via increasing the expression of SPP1
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/161161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Guijiang Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Laboratory Diagnosis and Research, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: The expression of miR-127 has been reported to be decreased in the breast tissue of patients with breast cancer (BRC). However, the mechanism of miR-127 involvement in the pathogenesis of BRC is still unclear and requires urgent clarification. OBJECTIVES: To explore the role of miR-127 in the pathogenesis of BRC. MATERIAL AND METHODS: In this study, we measured the expression of miR-127 in blood samples of 60 BRC patients and 60 controls, investigated the influence of miR-127 on the viability and apoptosis of MCF-7 and MDA-231 cells, identified a miR-127 target gene, and determined the expression level of the target gene in the blood samples of BRC patients and controls. RESULTS: We found that miR-127 expression was significantly decreased in the plasma of BRC patients compared to controls. Additionally, the upregulation of miR-127 in MCF-7 and MDA-231 cells inhibited their proliferation and promoted their apoptosis. Conversely, the downregulation of miR-127 promoted cell proliferation and inhibited their apoptosis. The SPP1 was successively predicted and validated as a target gene of miR-127. Finally, the expression level of SPP1 was significantly increased in the plasma of BRC patients compared to controls. CONCLUSIONS: Our study demonstrated that decreased miR-127 may promote BRC cell proliferation, inhibit apoptosis and promote the occurrence of BRC through increasing the SPP1 expression level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Laboratory Diagnosis and Research, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
- Baise Key Laboratory of Clinical Molecular Diagnosis, Research and Development for High Incidence Diseases, China.
- Key Laboratory of Clinical Molecular Diagnosis and Research for High Incidence Diseases in Western Guangxi Universities, Baise, China.
Zitieren
APA
Wei, G., Tan, M., Wang, C., & Liang, L. (2023). Decreased miR-127 promotes the occurrence of breast cancer via increasing the expression of SPP1. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/161161
Vancouver
Wei G, Tan M, Wang C, Liang L. Decreased miR-127 promotes the occurrence of breast cancer via increasing the expression of SPP1. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/161161
BibTeX
@article{Wei2023,
author = {Wei, Guijiang and Tan, Meiying and Wang, Chunfang and Liang, Lina},
title = {Decreased miR-127 promotes the occurrence of breast cancer via increasing the expression of SPP1},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/161161}
}
EUVIMED